Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA and ClinicalTrials.gov

Executive Summary

Industry compliance with the ClinicalTrials.gov database was discussed at a July 15 board meeting of the Pharmaceutical Research & Manufacturers of America. "The heads of regulatory affairs at PhRMA member companies have said they believe they are in compliance" with ClinicalTrials.gov posting requirements. Data cited by Rep. Henry Waxman (D-Calif.) during a recent congressional hearing do not reflect the current rate of compliance, PhRMA said (1"The Pink Sheet" July 12, 2004, p. 4). The association believes a "fairer evaluation would look at what our companies submitted in 2003 and so far this year"...
Advertisement

Related Content

ClinicalTrials.gov Compliance Will Improve, PhRMA Tells Rep. Waxman
ClinicalTrials.gov Compliance Will Improve, PhRMA Tells Rep. Waxman

Topics

Advertisement
UsernamePublicRestriction

Register

PS044362

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel